Ofev Rivals Hit US As Five Firms Get FDA Nod

Generic Nintedanib Approvals Follow Patent Expiry For $3.7bn Brand

 
• By Anabel Costa-Ferreira
  
FDA approved red key on keyboard.
(Shutterstock)

More from Generics

More from Generics Bulletin